Who we are
Our Management Team
Dr. Robin BrownChief Executive Officer
Immediately before joining KWS, Robin spent eight years as a venture partner at Advent Healthcare Ventures responsible for a number of companies within the portfolio. Previously he was the Chief Scientific Officer of Devgen and of Galapagos (EBR:DEVG, EBR:GLPG), both of which are now publically listed companies. Dr. Brown spent nine years at GSK, latterly as Head of Cell Biology. His academic career started with a PhD in the laboratory of Prof Alan Hall followed by postdoctoral positions at Harvard and the Ludwig Institute, London
Professor Neil WilliamsChief Scientific Officer
Professor Neil Williams is Founder and CSO of KWS BioTest. He has extensive experience in working with biotechnology and pharmaceutical companies supporting and advising on their drug discovery projects both preclinical and clinical. His positions have included Professor of Immunology and Head of Department at the University of Bristol and Chairman of the British Society for Immunology. He was also Founder of Aegis Pharmaceuticals Ltd (now Trident Pharmaceuticals Inc).
William ParishChief Operating Officer
Will Parish has a background in biotechnology having worked at Syngenta, before training to be an Army Officer at Sandhurst. After leaving the army, he joined KWS BioTest and led Project Management within the company before taking charge of operations in 2011. He was awarded his Master of Business Administration (MBA) in 2012.
Our Business Development Team
Leann QuinnBusiness Development
Dr Leann Quinn started as a drug discovery pharmacologist at GSK. She transitioned into a business development role 6 years ago and has worked for a number of international CROs during this time. Lee has been working with the KWS team for four years in a consultancy role, taking up a full time job with the KWS team in January 2015. Lee’s extensive network of contacts in the pharmaceutical and biotechnology industry has been instrumental in driving the growth of KWS. Lee is a regular at conferences and if you would like to catch up with her to discuss your requirements then please check our events page and make contact.LinkedIn Profile
Craig GormanBusiness Development
Craig Gorman is a Business Development professional with 20 years in the CRO, Lab and Pharma environment. Craig started his scientific sales career in diagnostics with Nichols Institute Diagnostics and Immuno Diagnostic Systems before transitioning to the Clinical Research Industry joining Omnicare CRO. Having gained valuable experience in clinical development, he focused on Central Lab services with a number of large CROs including LabCorp, Esoterix, ICON, Eurofins and Quintiles where he held various positions of responsibility in Business Development and Management. Craig brings experience in support of pharmaceutical clinical trials from Phase I to Phase III as KWS Biotest continues to grow its service offering in this area. His primary focus will be to promote early efficacy biomarkers in human clinical trials.LinkedIn Profile
Valérie VinceBusiness Development
Dr Valérie Vince graduated from the University Louis Pasteur, Strasbourg in 2000 with a BSc in Biological Sciences and MSC’s in both Cell Biology and Neurosciences. After undertaking her PhD in neuroimmunology at UCL Brussels, Valérie then joined Imperial College London’s team as a post doctoral researcher. Valérie joined KWS BioTest in 2008 as a Principal Scientist, before taking up the role of head of immunology. As of November 2015, Valérie has transitioned into the Business Development team at KWS to further strengthen the scientific expertise of the team. Valérie is frequently the first point of contact regarding in vivo models and pharmacology.LinkedIn Profile